Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke

Condition:   Acute Ischemic Stroke Interventions:   Drug: Xueshuantong lyophilized powder;   Drug: Xueshuantong lyophilized powder Placebo (Extremely low dose of Xueshuantong lyophilized powder);   Other: Guidelines-based standard care Sponsors:   Dongzhimen Hospital, Beijing;   Tianjin University of Traditional Chinese Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials